Photocure ASA is a Norwegian pharmaceutical company listed on Oslo Stock Exchange (PHO). The company develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology, targeting key dermatology and oncology markets.
Photocure has one product with sales and marketing approvals:
- Hexvix, for the detection of bladder cancer.
The product is based on the Photocure Technology, combining a drug known as a photosensitiser with a light source that activates the photosensitiser. Photocure is currently developing a pipeline of follow-on products and technologies.